Evaluating heart health factors after liver transplantation
Official title: Factors Associated With Short-Term Major Adverse Cardiovascular Events After Liver Transplantation
Run by Sun Yat-sen University · NCT06290154 · Data updated 2026-11-12
This study is testing if advanced heart imaging techniques can help doctors better understand and manage heart risks in patients getting a liver transplant.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Sun Yat-sen University Academic / other |
| Locations | 2 sites (Guangzhou, Guangdong and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | August 27, 2024 |
| Trial ID | NCT06290154 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years with end-stage cirrhosis who are scheduled for liver transplantation.
✕Probably not a fit
Patients with significant cardiac dysfunction or severe structural heart abnormalities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the cardiovascular outcomes in patients undergoing liver transplantation, focusing on the impact of various clinical and echocardiographic parameters. It aims to determine whether advanced echocardiographic techniques, such as speckle tracking and tissue Doppler imaging, can enhance preoperative risk assessment for patients with end-stage cirrhosis. By analyzing these factors, the study seeks to improve understanding of cardiac risks associated with liver transplantation and potentially guide better clinical decisions.
Why it matters
Potential benefit: If successful, this study could lead to improved preoperative risk stratification and better cardiac outcomes for liver transplant patients.
How similar studies have gone: While there is ongoing research in this area, the specific use of comprehensive echocardiographic multiparameters for risk stratification in liver transplant patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years, * End-stage cirrhosis patients who will receive liver transplantation, * Patients voluntarily take part in the study and write informed consent. Exclusion Criteria: * Decreased left ventricular systolic function (ejection fraction \<45%), * Significant uncorrectable structural cardiac abnormalities (eg, symptomatic coronary heart disease, advanced cardiomyopathy, severe valvular disease, severe congenital heart disease, etc), * Uncontrolled pulmonary hypertension defined as pulmonary arterial systolic pressure ≧ 35mm Hg at rest despite maximal medical management, * Circulatory or respiratory system with a score of 4 based on the preoperative Organ Dysfunction (CLIF-SOFA) score, * Second-time liver transplantation, * Combined organ transplantation, * Satisfactory quality echocardiography could not be obtained before operation.
Where it's running
-
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China Recruiting -
the Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Jia Liu, Dr
- Email: 395847953@qq.com
- Phone: 15920190962
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
One-stop photon-counting CT for patients after PCI
This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.